Necrotic cutaneous lesions induced by hypereosinophilic syndrome secondary to a T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 46, Issue 5 SUPPL., 2002, Pages

  Aractingi, Sélim ^a   Bachmeyer, Claude ^a   Pautier, Patricia ^b   Barboteu, Michel ^c   Meignin, Véronique ^d   Daniel, Marie Therese ^e   Marolleau, Jean Pierre ^b   Janin, Anne ^d  

^a HÔPITAL TENON   (France)

^b Service d'Hématologie

^c Service De Réanimation

^d Laboratoire De Pathologie EA 2378

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BRAIN INFARCTION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CELL ACTIVITY; CELL MIGRATION; CLINICAL FEATURE; DISEASE COURSE; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CELL; SKIN NECROSIS; SPLENECTOMY; T CELL LYMPHOMA; THROMBOSIS;

EID: 0036586859     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.107233     Document Type: Article

References (14)

1. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
2. Leiferman KM, O'Duffy JD, Perry HO, Greipp RP, Giuliani ER, Gleich GJ. Recurrent incapacitating mucosal ulcers: a prodrome of the hypereosinophilic syndrome. JAMA 1982;247:1018-20.
3. Aractingi S, Janin A, Zini JM, Gauthier MS, Chauvenet L, Tobelen G, et al. Specific mucosal erosions in hypereosinophilic syndrome: evidence for eosinophilic protein deposition. Arch Dermatol 1996;132:535-41.
4. Janin A, Torpier G, Capron M, Courtin P, Gosselin B. Immunopathological study of eosinophils in eosinophilc granuloma of bone: evidence for release of three cationic proteins and subsequent uptake in macrophages. Virchows Archiv A Pathol Anat 1992;421:255-61.
5. Mukai HY, Ninomiya H, Ohtani K, Nagasawa T, Abe T. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol 1995;90:892-9.
6. Frances C, Piette JC, Saada V, Papo T, Wechsler B, Chosidow O, et al. Multiple subungueal splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature. Lupus 1994;3:123-8.
7. Tai PC, Ackerman SJ, Spry CJF, Dunnette S, Olsen EG, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987;1:643-7.
8. Desreumaux P, Janin A, Dubucquoi S, Copin MC, Torpier G, Capron A, et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 1993;82:1553-60.
9. Cogan E, Schandané L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535-8.
10. Simon HU, Plötz AG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin 5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-20.
11. Gleich GJ, Schroeter AL, Marcoux P, Sachs MI, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med 1984;310:1621-6.
12. Dereure O, Meyer F, Ciurana AJ, Guilhou JJ. Dermatological manifestations of idiopathic hypereosinophilic syndrome: an unusual observation with protracted course and literature review. Eur J Dermatol 1994;4:110-6.
13. Chen KR, Pittelkow MR, Su WPD, Gleich JR, Newman W, Leiferman KM. Recurrent cutaneous eosinophilic necrotizing vasculitis: a novel eosinophil-mediated syndrome. Arch Dermatol 1994;130:1159-66.
14. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RJ. Human eosinophill adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelium leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 1991;88:7430-3.